IIPLA News
Wednesday, February 24, 2021

WTO TRIPS Waiver Alone Insufficient to Ensure Global Access to COVID-19 Medicines, Experts Warn

Despite calls for a temporary waiver on intellectual property rights to boost COVID-19 treatment availability, legal and practical barriers may limit its effectiveness, prompting…

IIPLA News Deskanonymous access0 articles left this week
WTO TRIPS Waiver Alone Insufficient to Ensure Global Access to COVID-19 Medicines, Experts Warn
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

The ongoing debate over intellectual property rights during the COVID-19 pandemic highlights the complex balance between incentivizing pharmaceutical innovation and ensuring equitable access to life-saving medicines. While South Africa and India have proposed a WTO TRIPS waiver to temporarily suspend IP protections on…
Share This Article
Ready-to-post copy includes the article link.

WTO TRIPS Waiver Alone Insufficient to Ensure Global Access to COVID-19 Medicines, Experts Warn The ongoing debate over intellectual property rights during the COVID-19 pandemic highlights the complex balance between incentivizing pharmaceutical innovation and ensuring equitable access to life-saving medicines. Wh... Read the full IIPLA article: https://iipla.org/news/wto-trips-waiver-alone-insufficient-to-ensure-global-access-to-covid-19-medicines-experts-warn

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsUK

UK Supreme Court Overhauls Patent Law Framework for AI and Neural Networks

The UK Supreme Court has delivered a pivotal judgment in Emotional Perception AI Ltd v Comptroller-General of Patents, Designs and Trade Marks, reshaping the legal approach to AI-based patent applications. The ruling discards the longstanding Aerotel test in favor of the European Patent Office’s framework, clarifies t…

Monday, June 22, 2026